T1	PROC 60 83	terapia antirretroviral
#1	AnnotatorNotes T1	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T2	DISO 540 548	Mutación
T3	DISO 175 190	infección HIV-1
T4	PROC 192 218	Estudio comparativo piloto
T5	DISO 243 258	Infección VIH-1
T6	DISO 384 393	infección
#2	AnnotatorNotes T6	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T7	PROC 435 437	WB
#3	AnnotatorNotes T7	C0005863; Western Blotting; Laboratory Procedure | C0949466; Western Blot; Laboratory Procedure
T8	PROC 534 536	WB
#4	AnnotatorNotes T8	C0005863; Western Blotting; Laboratory Procedure | C0949466; Western Blot; Laboratory Procedure
T9	DISO 629 650	Enfermedad oncológica
T10	DISO 661 674	Infección VHC
#5	AnnotatorNotes T10	C0019196; Hepatitis C; Disease or Syndrome
T11	CHEM 68 83	antirretroviral
#6	AnnotatorNotes T11	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T12	Date 13 17	2015
T13	LIVB 129 134	vIral
#7	AnnotatorNotes T13	C0042776; Virus; Virus
T14	PHYS 150 158	curación
#8	AnnotatorNotes T14	C2004454; Recovery - healing process; Organism Function
T15	LIVB 293 328	Hombres que tienen sexo con hombres
#9	AnnotatorNotes T15	C2827413; Men who have Sex with Men; Population Group
T17	LIVB 333 340	Hombres
#10	AnnotatorNotes T17	C0025266; Male population group; Population Group
T18	Age 341 359	entre 18 y 65 años
T19	Duration 363 380	Menos de 100 días
T20	LIVB 397 406	Pacientes
#11	AnnotatorNotes T20	C0030705; Patients; Patient or Disabled Group
T22	CHEM 470 473	p31
#12	AnnotatorNotes T22	C0644393; HIV-1 protein p31, Human immunodeficiency virus 1; Amino Acid, Peptide, or Protein · Biologically Active Substance
T24	CHEM 518 521	P31
#13	AnnotatorNotes T24	C0644393; HIV-1 protein p31, Human immunodeficiency virus 1; Amino Acid, Peptide, or Protein · Biologically Active Substance
T25	LIVB 671 674	VHC
#14	AnnotatorNotes T25	C0220847; hepatitis C virus; Virus
T26	LIVB 288 291	MSM
#15	AnnotatorNotes T26	C2827413; Men who have Sex with Men; Population Group
T16	LIVB 185 190	HIV-1
#16	AnnotatorNotes T16	C0019704; HIV-1; Virus
T27	LIVB 253 258	VIH-1
#17	AnnotatorNotes T27	C0019704; HIV-1; Virus
T21	Neg_cue 474 482	negativa
T23	GENE 557 561	CCR5
#18	AnnotatorNotes T23	C1332700; CCR5 gene; Gene or Genome
T28	PROC 563 572	HLA-B5701
#19	AnnotatorNotes T28	C3203663; HLA-B*5701 assay; Laboratory Procedure
T29	PROC 575 582	HLA-B27
#20	AnnotatorNotes T29	C2046362; human leukocyte antigen B27 (lab test); Laboratory Procedure
A1	Assertion T22 Negated
#21	AnnotatorNotes T4	C1579762; comparative study research; Research Activity + C0031928; Pilot Projects; Research Activity
#22	AnnotatorNotes T5	C2363741; HIV-1 infection; Disease or Syndrome
#23	AnnotatorNotes T2	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#24	AnnotatorNotes T9	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
R1	Has_Duration_or_Interval Arg1:T6 Arg2:T19	
T30	Quantifier_or_Qualifier 410 430	estadio Fiebig I a V
T31	Result_or_Value 438 446	negativo
#25	AnnotatorNotes T31	C0205160; Negative; Finding
R2	Has_Result_or_Value Arg1:T7 Arg2:T31	
R3	Negation Arg1:T21 Arg2:T22	
T32	Quantifier_or_Qualifier 449 459	incompleto
#26	AnnotatorNotes T32	C0205257; Incomplete; Qualitative Concept
R4	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T32	
T33	Result_or_Value 522 530	positiva
#27	AnnotatorNotes T33	C1446409; Positive; Finding
R8	Location_of Arg1:T23 Arg2:T2	
T34	Quantifier_or_Qualifier 549 556	Delta32
R9	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T34	
T35	Result_or_Value 583 592	positivas
#28	AnnotatorNotes T35	C1446409; Positive; Finding
R10	Has_Result_or_Value Arg1:T29 Arg2:T35	
R11	Has_Result_or_Value Arg1:T28 Arg2:T35	
R14	Overlap Arg1:T2 Arg2:T35	
R15	Causes Arg1:T25 Arg2:T10	
T36	Quantifier_or_Qualifier 651 657	activa
#29	AnnotatorNotes T36	C0679217; Active State; Idea or Concept
R16	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T36	
T37	Quantifier_or_Qualifier 675 681	activa
#30	AnnotatorNotes T37	C0679217; Active State; Idea or Concept
R17	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T37	
R18	Used_for Arg1:T11 Arg2:T1	
T38	Quantifier_or_Qualifier 84 94	muy precoz
R19	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T38	
R20	Causes Arg1:T16 Arg2:T3	
#31	AnnotatorNotes T3	C2363741; HIV-1 infection; Disease or Syndrome
R21	Causes Arg1:T27 Arg2:T5	
R22	Has_Age Arg1:T17 Arg2:T18	
R23	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T30	
T39	Quantifier_or_Qualifier 159 168	funcional
#32	AnnotatorNotes T39	C0205245; Functional; Functional Concept
R24	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T39	
T40	CONC 118 134	reservorio vIral
#33	AnnotatorNotes T40	C0012653; Disease Reservoirs; Idea or Concept (?)
R26	Before Arg1:T1 Arg2:T14	
R27	Before Arg1:T3 Arg2:T14	
A2	Experiencer T26 Patient
A3	Experiencer T15 Patient
A4	Experiencer T17 Patient
A5	Experiencer T20 Patient
T41	Result_or_Value 474 482	negativa
R6	Has_Result_or_Value Arg1:T8 Arg2:T33	
R12	Has_Result_or_Value Arg1:T7 Arg2:T41	
